FDA Prepares Review for CBD Regulation

The review seeks answers regarding long-term use and effects on pregnancy.

Agency officials from the Food and Drug Administration (FDA) have announced that they are beginning the process of reviewing the scientific evidence around the use of CBD. CBD (Cannabidiol) is a compound derived from cannabis and, though it has no psychoactive effects, it is widely advertised as a health supplement in all kinds of products. Because it is derived from cannabis and not actually a cannabis product itself, CBD is not currently regulated at the federal level.

The FDA is concerned about the safety of the compound and will compile relevant research in the coming months to see what kind of recommendations should be made regarding CBD regulation. Key questions they look to answer in their research are if the compound can be safely ingested for long periods of time and if its use has any impact on pregnancy.

As the Lord Leads, Pray with Us…

  • For Commissioner Robert Califf to seek God’s direction regarding the FDA’s priorities and focus.
  • For agency scientists as they seek answers surrounding the safety of CBD compounds.
  • For FDA officials as they gather and review information and data regarding CBD.

Sources: Wall Street Journal, Reuters


Back to top